In summary, we provide evidence supporting a tumor-specific role of TRPM8 rather than a tumor-specific expression of the channel, thus reinforcing the relevance of this channel as a promising candidate for prostate cancer therapy. This evidence concerns the gene TRPM8 and prostate carcinoma.